Generation Bio director Quinn Anthony buys shares for $203K by Investing.com
CAMBRIDGE, Mass.—Quinn Anthony G., CEO of Generation Bio Co. (NASDAQ:GBIO), recently made a significant purchase of the company’s stock, according to a recent filing with the SEC. On January 10th and January 13th, Anthony acquired a total of 210,791 shares of common stock, in transactions totaling approximately $203,209. The shares were acquired at a weighted average price ranging from $0.96 to $0.97 per share, slightly above the current trading price of $0.88. The stock has seen significant volatility, falling more than 66% in the past six months, according to InvestingPro data.
Following these transactions, Anthony’s direct ownership in the company increased to 299,286 shares. These purchases reflect an ongoing interest and investment in the future of the pharmaceutical company. Generation Bio Co. is headquartered in Cambridge, Massachusetts, and is focused on the development of innovative gene therapies. Although the company maintains a strong liquidity position with a current ratio of 6.34, InvestingPro analysis reveals both challenges and opportunities, with 12+ additional exclusive insights available to subscribers.
This article was generated with the support of artificial intelligence and reviewed by an editor. See our T&C for more information.